Drug Interaction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

so boost your bottom line by switching today. comcast business. powering possibilities.™ this is "don lemon tonight." prior primary season heating up. we'll look at the races. major shifts in the battle field in ukraine. >> translator: russia lost almost 27,000 soldiers, many of them young conscripts. russia lost more than 3,000 tanks, armored combat vehicles and a large number of conventional military vehicles, helicopters, drones and all of the prospects as a state. >> cnn cannot confirm those numbers and big news in the tech world, elon musk says he is putting his $44 billio...

Case Name: Genentech, Inc. v. Sandoz, Inc., Civ No. 23-4085 (JXN)(LDW), 2024 WL 939692 (D.N.J. Mar. 5, 2024) (Wettre, M.J.) - Drug Product and Patent(s)-in-Suit: Esbriet® (pirfenidone);...

Expert oncologists discuss the challenges and considerations in choosing second-line therapy for a patient with metastatic renal cell carcinoma (RCC) in a case-based context.

Beyond its primary role in diabetes treatment, SGLT-2 inhibitors have demonstrated versatility in various health aspects, offering benefits beyond glucose reduction.

The Hatch-Waxman Act established the U.S. Food and Drug Administration's approval and litigation process for generic drugs.